Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Cytosorbents (CTSO) Accumulated Depreciation & Amortization (2016 - 2025)

Cytosorbents' Accumulated Depreciation & Amortization history spans 15 years, with the latest figure at $5.1 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $5.1 million for Q4 2025, up 21.77% from a year ago — trailing twelve months through Dec 2025 was $5.1 million (up 21.77% YoY), and the annual figure for FY2025 was $5.1 million, up 21.77%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $5.1 million at Cytosorbents, down from $5.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.3 million in Q3 2025 to a low of $1.9 million in Q4 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $4.7 million (2021), against an average of $4.2 million.
  • The sharpest move saw Accumulated Depreciation & Amortization crashed 60.16% in 2022, then soared 60.07% in 2023.
  • Year by year, Accumulated Depreciation & Amortization stood at $4.8 million in 2021, then crashed by 60.16% to $1.9 million in 2022, then soared by 60.07% to $3.0 million in 2023, then skyrocketed by 39.19% to $4.2 million in 2024, then grew by 21.77% to $5.1 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $5.1 million, $5.3 million, and $5.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.